Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GP2015 vs Enbrel in Chronic Plaque Psoriasis
DRKS00005365Phase 3Completed
- Sponsor
- Hexal AG
- Start
- Oct 2013
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 12
01
Overview
Phase 3, randomised, double-blind trial in plaque psoriasis comparing GP2015 with Enbrel (2 arms). Started Oct 2013; status: completed.
02
Drugs
etanerceptomalizumab biosimilar SYN008
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on DRKS00005365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00005365.